The Royal Marsden supports new national programme of AI research to improve lung cancer screening

3 July 2020

Clinicians from The Royal Marsden NHS Foundation Trust are joining forces with other trusts and leading industrial partners across the UK to improve the diagnosis of lung cancer and other thoracic diseases using artificial intelligence.

Promising signs in early trial for personalised cancer vaccines

22 June 2020

Royal Marsden trial leads to practice changing milestone for advanced anal cancer

12 June 2020

Results from the first ever randomised clinical trial in advanced anal cancer patients, led and supported by The Royal Marsden NHS Foundation Trust and Cancer Research UK, in collaboration with colleagues in the US, Norway and Australia, has led to a practice changing milestone with a new approach to treatment which is safer and more effective than previously recommended treatments for this group of patients.

New guidance helps select breast cancer patients for urgent surgery or chemotherapy during pandemic

8 June 2020

A new approach to better select breast cancer patients in need of urgent surgery or chemotherapy during the COVID-19 pandemic has been developed by researchers at The Royal Marsden and the Breast Cancer Now Research Centre at The Institute of Cancer Research, London, in collaboration with colleagues in the UK, Germany and US.

The ‘Marsden Manual’ celebrates its 10th edition

4 June 2020

Today, Thursday 4 June, The Royal Marsden NHS Foundation Trust launches the publication of the latest edition of The Royal Marsden Manual of Clinical Nursing Procedures – internationally renowned and relied on by nurses across the spectrum of healthcare settings.

‘Significant’ results show drug combination better tolerated

2 June 2020

Researchers say treatment could be better tolerated by breast cancer patients

New optimised intensity-modulated radiation therapy can reduce swallowing difficulties for head and neck cancer patients

30 May 2020

A new optimised intensity-modulated radiation therapy (IMRT) pioneered at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, has been shown to spare head and neck cancer patients’ adverse life-long side effects post treatment.

Combination immunotherapy drugs herald new hope for patients with rare type of melanoma

30 May 2020

A combination of two immunotherapy drugs, ipilimumab and nivolumab, has stopped or reversed the progression of advanced melanoma in some patients with mucosal melanoma for five years, according to a study co-led by The Royal Marsden NHS Foundation Trust.